Cargando…
Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration
BACKGROUND: To quantitatively evaluate the vitreomacular interface of eyes with neovascular age-related macular degeneration (AMD) and to investigate its association with the 1-year treatment outcome following intravitreal injections of aflibercept (IVA). METHODS: This prospective observational case...
Autores principales: | Miyata, Manabu, Ooto, Sotaro, Yamashiro, Kenji, Tamura, Hiroshi, Uji, Akihito, Miyake, Masahiro, Muraoka, Yuki, Takahashi, Ayako, Tsujikawa, Akitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690868/ https://www.ncbi.nlm.nih.gov/pubmed/34930502 http://dx.doi.org/10.1186/s40942-021-00342-4 |
Ejemplares similares
-
Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration
por: Hosoda, Yoshikatsu, et al.
Publicado: (2020) -
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
por: Nishikawa, Keiichi, et al.
Publicado: (2019) -
Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
por: Elfandi, Sufian, et al.
Publicado: (2021) -
Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds
por: Yamashiro, Kenji, et al.
Publicado: (2020) -
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
por: Tamiya, Ryosuke, et al.
Publicado: (2023)